4-Chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine

Catalog No. :
ACLAPR837
CAS No. :
2092627-98-8
Molecular Formula :
C7H3ClF2N2S
Molecular Weight :
220.63

IUPAC Name:4-chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine

4-Chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$95.00Login to see priceInquiryInquiry
100mg97%$169.00Login to see priceIn stockInquiry
250mg97%$287.00Login to see priceIn stockInquiry
1g97%$772.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine
IUPAC Name4-chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine
MDL No.MFCD29767670
Molecular FormulaC7H3ClF2N2S
Molecular Weight220.63
SMILESFC(C1=CC2=NC=NC(Cl)=C2S1)F
InChI KeyILPPKTLVHFEZSG-UHFFFAOYSA-N
Synonym4-Chloro-6-(difluoromethyl)thieno[3,2-d]pyrimidine;Thieno[3,2-d]pyrimidine, 4-chloro-6-(difluoromethyl)-
CAS No.2092627-98-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLAPR837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRKVG431 route compound structure diagram
    ACRKVG431225382-62-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLAPR837 route product structure diagram
    ACLAPR8372092627-98-8 In Stock
Inquiry

2. ACLAPR837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRKVG431 route compound structure diagram
    ACRKVG431225382-62-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLAPR837 route product structure diagram
    ACLAPR8372092627-98-8 In Stock
Inquiry

Comments (0)